<DOC>
	<DOCNO>NCT01217879</DOCNO>
	<brief_summary>In light ONTARGET TRANSCEND study result , would interest investigate real-life telmisartan treatment tolerability . It well know accept Real-life set much adequate reflect antihypertensive safety property drug comparison organize schedule set clinical trial . Because much data cough relation telmisartan , therefore would worth observe cough frequency general treatment tolerance patient treat telmisartan , stop previous ACE-I treatment due cough .</brief_summary>
	<brief_title>COugh Among Hypertensive Patients Treated With Telmisartan , Who Had Stop previoUs ACE-i Treatment Due couGH Slovakia</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Hypertension Age &gt; 18 ACEI related cough Current treatment telmisartan Cholestatic disorder severe hepatic failure Allergy telmisartan Pregnancy lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Cough</keyword>
	<keyword>Telmisartan</keyword>
	<keyword>Bradykinin</keyword>
	<keyword>Tolerability</keyword>
</DOC>